Region
China cell therapy developer Neowise raises $29m
Chinese cell therapy company Neowise has raised an extended Series A round of CNY200m (USD 29m) from a group including Oriza Seed Fund Management and Marathon Venture Partners.
GPs double down on value creation to maintain returns - AVCJ Forum
Private equity investors must find more operational levers to pull as LPs seek the same if not higher returns from the asset class despite more challenging economic conditions.
ADIA invests $500m in India's Lenskart
Abu Dhabi Investment Authority (ADIA) has agreed to invest USD 500m in Indian eyewear retailer Lenskart. It would bring pre-IPO funding in the past 12 months to around USD 750m.
Australian HNWIs want more PE exposure, but obstacles remain - AVCJ Forum
Private equity may not be proven in the eyes of Australia’s high net worth investors, most of whom haven’t been exposed to the asset class across multiple cycles, but it earned wider recognition last year as public equities and fixed income struggled....
Heritas hits $20m first close on Asia impact fund
Singapore-based private equity firm Heritas Capital has reached a first close of USD 20m on its latest Asia impact fund against an overall target of USD 50m. DBS contributed USD 10m.
CVC invests $155m in Indonesia gas company
CVC Capital Partners has committed USD 155m to Indonesia-listed Samator Indo Gas, the largest industrial and medical gas producer in the country.
India's HealthPlix raises $22m Series C
India’s HealthPlix, a medical records platform for doctors that aims to democratize access to digital healthcare in remote areas, has raised a USD 22m Series C round led by Avataar Venture Partners.
China UAV player United Aircraft raises $290m
United Aircraft, a Chinese start-up specialising in unmanned aerial vehicles (UAVs), has raised a Series D of CNY 2bn (USD 290m) from an assortment of local investors.
India's Rockstud targets $37m for sophomore angel fund
India’s Rockstud Capital, an early-stage VC investor backed by high net worth individuals, has launched its second angel fund with a target of INR 3bn (USD 37m).
Japan's Anri leads $27m round for start-up lending platform
Japanese venture capital firm Anri has led a JPY 3.6bn (USD 27m) Series D round for local start-up lending platform Funds.
China IPOs: Back to New York
With regulatory challenges receding, Chinese companies are once again targeting US listings. But the journey to New York – in terms of approvals, locations, and valuations – isn’t necessarily smooth
Deal focus: Glimmer in a dormant Pakistani ecosystem
Pakistan’s Trukkr quietly spent a hardscrabble pre-seed period building infrastructure while competitors leveraged a short-lived VC boom to grow quickly. The patience appears set to pay off
Deal focus: K-wave media savvy explores new markets
Korean audience interaction technology provider Bemyfriends hopes a sizeable Series A round led by Cleveland Avenue, a lifestyle-focused VC firm in the US, will jumpstart a global expansion
Deal focus: Mapping malls and metaverses
Mapxus sees indoor maps of high-traffic areas in high-density cities as the last piece of infrastructure to digitalise. The Hong Kong start-up has won corporate and VC backing to expand region-wide
LP interview: North East Private Equity Asia
Seven years ago, Sam Robinson was invited to build a European family office’s Asia private equity portfolio from the ground up. He favoured familiar faces in the small to mid-cap space
BPEA EQT hits first close on mid-market fund, seals debut deal
BPEA EQT – which was formed through the merger of Baring Private Equity Asia and EQT – achieved a first close on its pan-regional mid-cap fund at the end of last year and the vehicle recently completed its debut investment in a Malaysia-headquartered...
Kedaara buys majority stake in India dermatology player
Kedaara Capital has acquired a majority stake in medico-aesthetic dermatology services Oliva Skin & Hair Clinic, facilitating an exit for healthcare specialist InvAscent Capital.
China artificial heart developer raises $100m
China-based medical device manufacturer Evaheart has raised a Series A of close to USD 100m led by Chinese vaccine developer Sinovac.
China industrial supplies platform ZKH pursues US IPO
ZKH Group, a China-based industrial supplies platform backed by the likes of Eastern Bell Capital, Genesis Capital, Tencent Holdings, and Tiger Global Management, has filed to list in the US.
Blackstone completes exit from India's Sona Comstar
The Blackstone Group has completed a staged exit from India-listed automotive industry supplier Sona Comstar, selling its remaining 20.5% via bulk open market deals worth about USD 600m.
Silicon Valley Bank's China JV reassures stakeholders
SPD Silicon Valley Bank, the China-based joint venture of SVB Financial Group, has offered assurances about the robustness of its operations following the closure of SVB Financial-owned US lender Silicon Valley Bank (SVB), while listed Chinese clients...
Australian GPs look to retain spirit of entrepreneurship - AVCJ Forum
The combination of personalities and skillsets that characterised the first generation of Australian private equity is unlikely to be repeated, but GPs are still looking for ways to capture elements of entrepreneurialism even as the industry becomes more...
Qiming, Ince invest in China, US biotech start-up
Qiming Venture Partners and Ince Capital have led a USD 50m Series B round for China and US-based oncology and autoimmune diseases treatments developer Allorion Therapeutics.